Virus News and Research

Latest Virus News and Research

Scientists identify two drug candidates that counteract deficiencies caused by lack of MECP2 gene

Most autism spectrum disorders have a complex, multifactorial genetic component, making it difficult to find specific treatments. Rett syndrome is an exception.

9 Dec 2020

Interim results show Oxford COVID-19 vaccine protects against symptomatic disease

First full results from interim analysis confirm that the Oxford COVID-19 vaccine (AZD1222) has an acceptable safety profile and is efficacious against symptomatic COVID-19 disease, with no hospitalizations or severe disease reported in the COVID-19 vaccine group so far.

9 Dec 2020

Researchers compare data from blood donors to infer the attack rate of SARS-CoV-2 virus

Researchers studying data from blood donors in Manaus, Brazil, who experienced high mortality from SARS-CoV-2, estimate that more than 70% of the population was infected approximately seven months after the virus first arrived in the city.

9 Dec 2020

Scientists determine key molecular processes used by coronavirus to infect human cells

When a coronavirus--including SARS-CoV-2, which causes COVID-19--infects someone, it hijacks the person's cells, co-opting their molecular machinery for its own survival and spread.

9 Dec 2020

New report underscores the need to implement home care in all pandemic planning

Tens of thousands of Massachusetts residents depend on home care to support their health as they age or cope with physical challenges. That care often requires close personal contact, increasing the risk of contracting COVID-19 among both home-care clients and the aides who provide their care.

8 Dec 2020

Researchers assess the binding behavior of SARS-CoV-2 virus

The binding of a SARS-CoV-2 virus surface protein spike -- a projection from the spherical virus particle -- to the human cell surface protein ACE2 is the first step to infection that may lead to COVID-19 disease.

8 Dec 2020

Amilorides reduce SARS-CoV-2 viral replication in vitro

A new U.S. study published on the bioRxiv preprint server reports the use of an amiloride-based scaffold that targets a viral RNA structure known to be essential in viral replication in the 5’-untranslated region (UTR) of the virus. The researchers say this heralds the application of these molecules as chemical probes to explore viral biology and produce specific antivirals targeting RNA regions of the coronavirus genome.

8 Dec 2020

UC Davis Health joins with Novavax to test a new experimental coronavirus vaccine

Despite the encouraging news of potentially successful COVID-19 vaccine trials, there is not yet an FDA-approved vaccine available. Research into other effective coronavirus vaccines continues, including at UC Davis Health.

8 Dec 2020

People with Bartonella infection exhibit neuropsychiatric symptoms, skin lesions

Bartonella bacteria are increasingly recognized as an emerging infectious disease threat. A new study by North Carolina State University researchers has found additional instances of Bartonella infection in humans who exhibited neuropsychiatric symptoms, a subset of whom also had skin lesions.

8 Dec 2020

FASLG gene may drive cytokine-linked adverse COVID-19 outcomes with age

A new study published on the preprint server bioRxiv in December 2020 reveals the role played by certain genetic factors in this group, in particular the FASLG gene belonging to the tumor necrosis factor (TNF) family.

8 Dec 2020

Troublesome COVID-19 symptoms could last more than 6 weeks

Physicians in Geneva have shown that some of the troublesome symptoms of COVID-19 could last more than 6 weeks, even in patients without underlying risk factors.

8 Dec 2020

High-performing multi-immunoassay for early diagnosis and prognosis of COVID-19

A new study published on the preprint server bioRxiv in December 2020 indicates the ability of anti-SARS-CoV-2 antibody titers and time of induction to differentiate between severe and mild COVID-19 and could lead to the development of a prognostic biomarker for use early in the course of the illness.

8 Dec 2020

Why is COVID-19 more severe among adults than children?

Researchers in Switzerland and Australia have reviewed some of the mechanisms proposed regarding why coronavirus disease 2019 (COVID-19) is generally less severe among children than among adults.

8 Dec 2020

Scientists provide insight on how lung bacteria protect against invading pathogens

New insight on how bacteria in the lungs protect against invading pathogens has been published today in the open-access eLife journal.

8 Dec 2020

Tension between awareness and fatigue can shift the shape of coronavirus pandemic

In the midst of the coronavirus pandemic, two human factors are battling it out: awareness of the virus's severe consequences and fatigue from nine months of pandemic precautions.

8 Dec 2020

Researchers find elevated biomarker for blood vessel damage in children with SARS-CoV-2

Researchers at Children's Hospital of Philadelphia have found elevated levels of a biomarker related to blood vessel damage in children with SARS-CoV-2 infection, even if the children had minimal or no symptoms of COVID-19.

8 Dec 2020

Reducing aerosol transmission could help tackle COVID-19 pandemic

Aerosols and their spread play an essential role in the transmission of COVID-19. However, the risk of transmission could be significantly reduced if more could be done to reduce indoor airborne viruses.

8 Dec 2020

COVID-19 may be linked to acute appendicitis in children

Researchers at the University of Virginia have recently presented a case series pointing to a potential association between infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the development of acute appendicitis in children.

8 Dec 2020

Transmission dynamics of SARS-CoV-2 in children: an Indian case study

Researchers have studied the primary contacts of COVID-19 positive children in India in May 2020 and found all children to be asymptomatic, and only four of the parents became positive. Although this suggests lower transmission from children, no recommendations can be made yet on school reopening.

8 Dec 2020

Peracetic acid fumigation as powerful and cost-effective disinfectant of SARS-CoV-2 on surfaces

In a recent study, researchers at the Public Health Agency of Canada found that dry fog fumigation using peracetic acid (PAA) completely deactivated SARS-CoV-2 on all nine of their test surfaces.

8 Dec 2020

Virus News and Research

Latest Virus News and Research

Scientists identify two drug candidates that counteract deficiencies caused by lack of MECP2 gene

Interim results show Oxford COVID-19 vaccine protects against symptomatic disease

Researchers compare data from blood donors to infer the attack rate of SARS-CoV-2 virus

Scientists determine key molecular processes used by coronavirus to infect human cells

New report underscores the need to implement home care in all pandemic planning

Researchers assess the binding behavior of SARS-CoV-2 virus

Amilorides reduce SARS-CoV-2 viral replication in vitro

UC Davis Health joins with Novavax to test a new experimental coronavirus vaccine

People with Bartonella infection exhibit neuropsychiatric symptoms, skin lesions

FASLG gene may drive cytokine-linked adverse COVID-19 outcomes with age

Troublesome COVID-19 symptoms could last more than 6 weeks

High-performing multi-immunoassay for early diagnosis and prognosis of COVID-19

Why is COVID-19 more severe among adults than children?

Scientists provide insight on how lung bacteria protect against invading pathogens

Tension between awareness and fatigue can shift the shape of coronavirus pandemic

Researchers find elevated biomarker for blood vessel damage in children with SARS-CoV-2

Reducing aerosol transmission could help tackle COVID-19 pandemic

COVID-19 may be linked to acute appendicitis in children

Transmission dynamics of SARS-CoV-2 in children: an Indian case study

Peracetic acid fumigation as powerful and cost-effective disinfectant of SARS-CoV-2 on surfaces

A new way of characterising biomolecules eBook

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Newsletters you may be interested in